Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114693703 | 11469370 | 3 | F | 20160704 | 20160705 | 20150908 | 20160715 | EXP | US-GLAXOSMITHKLINE-US2015124848 | GLAXOSMITHKLINE | 61.38 | YR | M | Y | 0.00000 | 20160715 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114693703 | 11469370 | 1 | PS | FLOVENT DISKUS | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 250 MCG | Y | 20833 | 1 | DF | INHALATION POWDER | BID | |||||
| 114693703 | 11469370 | 2 | SS | FLOVENT DISKUS | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 500 MCG | Y | 20833 | 1 | DF | INHALATION POWDER | BID | |||||
| 114693703 | 11469370 | 3 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | Y | 0 | 1 | DF | INHALATION POWDER | BID | |||||
| 114693703 | 11469370 | 4 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 2 PUFF(S), BID | 0 | 2 | DF | BID | |||||||
| 114693703 | 11469370 | 5 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Unknown | UNK | U | 4ZP4797 | 0 | ||||||||
| 114693703 | 11469370 | 6 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
| 114693703 | 11469370 | 7 | C | ALBUTEROL. | ALBUTEROL | 1 | U | 0 | |||||||||||
| 114693703 | 11469370 | 8 | C | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | U | 0 | |||||||||||
| 114693703 | 11469370 | 9 | C | MUCINEX | GUAIFENESIN | 1 | U | 0 | |||||||||||
| 114693703 | 11469370 | 10 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114693703 | 11469370 | 1 | Bronchitis chronic |
| 114693703 | 11469370 | 3 | Bronchitis chronic |
| 114693703 | 11469370 | 4 | Bronchitis chronic |
| 114693703 | 11469370 | 5 | Cough |
| 114693703 | 11469370 | 6 | Dyspnoea |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114693703 | 11469370 | Asthenia | |
| 114693703 | 11469370 | Cough | |
| 114693703 | 11469370 | Decreased immune responsiveness | |
| 114693703 | 11469370 | Device use error | |
| 114693703 | 11469370 | Drug ineffective | |
| 114693703 | 11469370 | Dysphonia | |
| 114693703 | 11469370 | Dyspnoea | |
| 114693703 | 11469370 | Gait disturbance | |
| 114693703 | 11469370 | Hyperchlorhydria | |
| 114693703 | 11469370 | Hypersensitivity | |
| 114693703 | 11469370 | Lung disorder | |
| 114693703 | 11469370 | Medication residue present | |
| 114693703 | 11469370 | Musculoskeletal chest pain | |
| 114693703 | 11469370 | Productive cough | |
| 114693703 | 11469370 | Respiratory symptom | |
| 114693703 | 11469370 | Retching | |
| 114693703 | 11469370 | Sleep apnoea syndrome | |
| 114693703 | 11469370 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114693703 | 11469370 | 1 | 2014 | 0 | ||
| 114693703 | 11469370 | 3 | 2015 | 0 | ||
| 114693703 | 11469370 | 5 | 201508 | 0 |